BioHarvest Sciences Surpasses USD $1.0 Million in Cumulative Direct Sales of Coffee with VINIA Inside
BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) has announced that its VINIA® Superfood Coffee and Decaf Coffee product line has surpassed USD $1.0 million in cumulative sales since its launch in December 2023. The coffee pods, compatible with Keurig® systems, contain the company's flagship VINIA® Red Grape Superfood, which claims to improve physical energy and mental alertness through increased blood flow.
Key highlights include:
- 4.8/5.0 customer rating with over 136 verified reviews
- 59% of coffee drinkers prefer VINIA® Superfood Coffee in blind taste tests
- 68% prefer VINIA® Superfood Decaf over a leading Amazon decaf brand
- Q1 2024 gross profit of US$3.0 million (56% of total Product revenues)
- Plans to launch Nespresso® compatible pods before year-end
The company sees this milestone as validation of its strategy to enter major categories with innovative, functional health and wellness solutions.
BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ha annunciato che la sua linea di prodotti VINIA® Superfood Coffee e Decaf Coffee ha superato 1,0 milioni di dollari USA in vendite cumulative dalla sua lanci del dicembre 2023. Le capsule di caffè, compatibili con i sistemi Keurig®, contengono il superfood principale dell'azienda, VINIA® Red Grape, che promette di migliorare l'energia fisica e la prontezza mentale tramite un aumento del flusso sanguigno.
I punti salienti includono:
- valutazione dei clienti di 4,8/5,0 con oltre 136 recensioni verificate
- il 59% dei bevitori di caffè preferisce il VINIA® Superfood Coffee in test di assaggio alla cieca
- il 68% preferisce il VINIA® Superfood Decaf rispetto a un marchio di decaffeinato leader su Amazon
- utile lordo nel primo trimestre del 2024 di 3,0 milioni di USD (56% delle entrate totali dai prodotti)
- programma per lanciare capsule compatibili con Nespresso® entro la fine dell'anno
L'azienda considera questo traguardo come una validazione della sua strategia di entrare in categorie importanti con soluzioni innovative e funzionali per la salute e il benessere.
BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ha anunciado que su línea de productos VINIA® Superfood Coffee y Decaf Coffee ha superado 1.0 millones de dólares estadounidenses en ventas acumuladas desde su lanzamiento en diciembre de 2023. Las cápsulas de café, compatibles con los sistemas Keurig®, contienen el superalimento insignia de la compañía, VINIA® Red Grape, que afirma mejorar la energía física y la alerta mental a través de un aumento del flujo sanguíneo.
Los puntos destacados incluyen:
- calificación de cliente de 4.8/5.0 con más de 136 reseñas verificadas
- el 59% de los bebedores de café prefieren el VINIA® Superfood Coffee en pruebas de sabor a ciegas
- el 68% prefiere el VINIA® Superfood Decaf frente a una marca de descafeinado líder en Amazon
- utilidad bruta en el primer trimestre de 2024 de 3.0 millones de USD (56% de los ingresos totales de productos)
- planes para lanzar cápsulas compatibles con Nespresso® antes de fin de año
La empresa considera este hito como una validación de su estrategia para entrar en categorías importantes con soluciones innovadoras y funcionales de salud y bienestar.
BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF)는 VINIA® 슈퍼푸드 커피와 디카페인 커피 제품 라인이 2023년 12월 출시 이후 100만 달러 이상의 누적 판매를 기록했다고 발표했습니다. 커피 포드는 Keurig® 시스템과 호환되며, 회사의 주력 제품인 VINIA® 레드 포도 슈퍼푸드를 포함하고 있어 혈류 증가를 통해 신체 에너지와 정신적 경계를 개선한다고 주장합니다.
주요 하이라이트는 다음과 같습니다:
- 136건 이상의 인증된 리뷰로 고객 평가 4.8/5.0
- 커피 소비자의 59%가 블라인드 테스트에서 VINIA® 슈퍼푸드 커피를 선호
- 68%가 유명한 아마존 디카페인 브랜드보다 VINIA® 슈퍼푸드 디카페인을 선호
- 2024년 1분기 매출 총 이익 300만 달러(총 제품 수익의 56%)
- 연말까지 네스프레소® 호환 포드를 출시할 계획
회사는 이 이정표를 주요 카테고리에 혁신적이고 기능적인 건강 및 웰빙 솔루션으로 진입하는 전략에 대한 검증으로 보고 있습니다.
BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) a annoncé que sa gamme de produits VINIA® Superfood Coffee et Decaf Coffee a dépassé 1,0 million USD de ventes cumulées depuis son lancement en décembre 2023. Les dosettes de café, compatibles avec les systèmes Keurig®, contiennent le superaliment phare de l'entreprise, VINIA® Red Grape, qui prétend améliorer l'énergie physique et la vigilance mentale grâce à une augmentation du flux sanguin.
Les faits saillants incluent :
- note client de 4,8/5,0 avec plus de 136 avis vérifiés
- 59% des amateurs de café préfèrent le VINIA® Superfood Coffee lors de tests de goût à l'aveugle
- 68% préfèrent le VINIA® Superfood Decaf par rapport à une marque de café décaféiné leader sur Amazon
- bénéfice brut de 3,0 millions USD au premier trimestre 2024 (56% des revenus totaux des produits)
- prévisions de lancement des dosettes compatibles avec Nespresso® avant la fin de l'année
La société considère cette étape comme une validation de sa stratégie d'entrée sur des catégories majeures avec des solutions de santé et de bien-être innovantes et fonctionnelles.
BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) hat angekündigt, dass die Produktlinie VINIA® Superfood Coffee und Decaf Coffee über 1,0 Millionen USD an kumulierten Verkäufen seit ihrer Einführung im Dezember 2023 überschritten hat. Die Kaffeekapseln, die mit Keurig®-Systemen kompatibel sind, enthalten das Flaggschiffprodukt VINIA® Red Grape Superfood des Unternehmens, das behauptet, die körperliche Energie und die geistige Wachsamkeit durch erhöhten Blutfluss zu verbessern.
Wichtige Highlights sind:
- Kundenbewertung von 4,8/5,0 mit über 136 geprüften Bewertungen
- 59% der Kaffeetrinker bevorzugen VINIA® Superfood Coffee bei Blindverkostungen
- 68% bevorzugen VINIA® Superfood Decaf gegenüber einer führenden Decaf-Marke auf Amazon
- Bruttogewinn im ersten Quartal 2024 von 3,0 Millionen USD (56% des gesamten Produktumsatzes)
- Pläne zur Einführung von Nespresso®-kompatiblen Kapseln vor Jahresende
Das Unternehmen sieht diesen Meilenstein als Validierung seiner Strategie, in wichtige Kategorien mit innovativen, funktionalen Gesundheits- und Wellnesslösungen einzutreten.
- Surpassed USD $1.0 million in cumulative sales for VINIA® Superfood Coffee since December 2023 launch
- Achieved 4.8/5.0 customer rating with over 136 verified reviews
- 59% of coffee drinkers prefer VINIA® Superfood Coffee in blind taste tests
- Q1 2024 gross profit increased to US$3.0 million (56% of total Product revenues) from US$0.8 million (37%) in Q1 2023
- Plans to expand product line with Nespresso® compatible pods before year-end
- Net loss of US$6.6 million in Q1 2024
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - August 28, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that its VINIA® Superfood Coffee and Decaf Coffee, a "functional" coffee product line integrating flagship nutraceutical product VINIA® Red Grape Superfood into a premium coffee in the popular Keurig compatible pod format, has surpassed USD
Photo of 30 Day Supply of VINIA Superfood Coffee
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/6168/221376_c5de4400347d5bb7_001full.jpg
VINIA® Superfood Coffee is made with premium
Since launch, VINIA® Superfood Coffee has achieved a best-in-class verified customer rating via its website of 4.8 out of 5.0 with over 136 verified reviews, demonstrating its significant positive impact on consumers' lives.**
In a blind taste-test of coffee drinkers (N=76),
"Our strategy to enter major categories seeking innovation, where consumers are demanding more functionality and health and wellness solutions, has been validated by the strong sales of our recently launched VINIA® Superfood Coffees with its Superior Science, Superior Efficacy and Superior Taste strategy," said Ilan Sobel, CEO of BioHarvest Sciences. "We have made significant progress in just a few months in our efforts to gain market share in the Functional Coffee market, amid rising consumer demand for coffee solutions with increased health benefits. VINIA® Hot Beverages expands usage occasions for VINIA®, increases our user base with younger audiences, and provides higher gross profit per equivalent unit.
"Looking ahead for the Hot Beverages business, we expect to add new Nespresso® compatible pods with VINIA® Superfood Coffee before year end, which has received blind taste test parity with a major Nespresso line amongst espresso coffee drinkers. Today's
In Q1 2024, the first full quarter following the introduction of VINIA® Coffees, Gross profit was US
* The Global Functional Coffee Market is estimated to be
* The Global Functional Tea Market is estimated to be
** BioHarvest Sciences encourages all product customers to leave honest and uncensored feedback. Product customers receive a 30-day supply when they submit a review, whether positive or negative.
About BioHarvest Sciences Inc.
BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) is a leader in Botanical Synthesis, leveraging its patented technology platform to grow plant-based molecules, without the need to grow the underlying plant. BioHarvest is leveraging its botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two major business verticals; as a contract development and production organization (CDMO) on behalf of customers seeking complex molecules, and as a creator of proprietary nutraceutical health and wellness products, which includes dietary supplements. To learn more, please visit www.bioharvest.com.
Forward-Looking Statements
Information set forth in this news release might include forward-looking statements that are based on management's current estimates, beliefs, intentions, and expectations, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Launching new products is subject to risks and uncertainties including the risk that the market will not accept the product or that government approvals required for sale or import of the products will not be obtained. There is never an assurance that any product set will successfully disrupt established product categories. All forward-looking statements are inherently uncertain and actual results may be affected by a number of material factors beyond our control. Readers should not place undue reliance on forward-looking statements. BHSC does not intend to update forward-looking statement disclosures other than through our regular management discussion and analysis disclosures.
*Note: VINIA® has no affiliation with Keurig Dr. Pepper Inc. or Nespresso®. "Keurig®" and "K-Cup®" are registered trademarks of Keurig Dr. Pepper Inc.
Neither the Canadian Securities Exchange nor its Regulation Services Provider accept responsibility for the adequacy or accuracy of this release.
This release has been reviewed and approved by Dave Ryan, VP Investor Relations, who accepts responsibilities for its contents.
BioHarvest Corporate Contact:
Dave Ryan, VP Investor Relations & Director
+1 (604) 622-1186
info@bioharvest.com
Investor Relations Contact:
Lucas A. Zimmerman
Managing Director
MZ Group - MZ North America
+1 (949) 259-4987
BHSC@mzgroup.us
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/221376
FAQ
What is BioHarvest Sciences' stock symbol?
How much has VINIA® Superfood Coffee sales generated since its launch?
What was BioHarvest Sciences' gross profit in Q1 2024?
How did VINIA® Superfood Coffee perform in blind taste tests?
What new product is BioHarvest Sciences planning to launch?
